≡ Risteys
FG R12 + FR

Documentation Changelog GitHub Contact & Feedback
info icon

This is a non-core endpoint: only basic statistics are computed.

See its core counterpart C3_FEMALE_GENITAL_NAS_EXALLC for full statistics.

Malignant neoplasm of other and unspecified female genital organs

DOID Endpoint Browser

C3_FEMALE_GENITAL_NAS

Endpoint definition

↥

Endpoint definition steps

FinnGen

Phenotype data

520210

1. Apply sex-specific rule

only females

293373

2. Check conditions

None

293373

3. Check pre-conditions, main-only, mode, registry filters

Registry filters:

  • Cause of death: ICD-10 — C57
  • Cause of death: ICD-9 — 184
  • Cause of death: ICD-8 — 183
  • Cause of death: excluded ICD-8 — 1830
  • Cancer registry: Topography ICD-O-3 — C57
  • Cancer registry: Morphology ICD-O-3 — ANY
  • Cancer registry: Behaviour codes — 3

2 out of 7 registries used, show all original rules.

437

4. Check minimum number of events

None

437

5. Include endpoints

None

437

6. Filter based on genotype QC (FinnGen only)

437

Control definitions (FinnGen only)

Controls for this endpoint are individuals that are not cases.

Extra metadata

Level in the ICD hierarchy
3
First used in FinnGen datafreeze
DF9

Similar endpoints

↥

List of similar endpoints to Malignant neoplasm of other and unspecified female genital organs based on the number of shared cases.

Venn diagram with an highlighted set fully inside another set Similar with more cases:

Venn diagram with a set fully inside an highlighted set Similar with less cases:

None

Case counts by codes

↥

FinnGen case counts by registry codes:

generic upset plot

Upset plot

Full data table

Summary Statistics

↥

-FinRegistry-

This endpoint is excluded from FinRegistry analyses (omitted endpoint).

-FinnGen-

Key figures

All Female Male
Number of individuals 437 437 -
Unadjusted period prevalence (%) 0.15 0.15 -
Median age at first event (years) 68.44 68.44 -

-FinnGen-

Age distribution of first events

-FinnGen-

Year distribution of first events

-FinnGen-

Cumulative Incidence Function

Not a core endpoint, no data to show.

CodeWAS (R11)

↥

CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.

This is a new tool, please reach out using the contact form for feedback and improvement ideas.

First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log10(p-value) ≥ 6.

Matched cohort

Matched cases
401
Matched controls
4009
Code
Vocabulary
Description
Odds Ratio
-log10(p)
N matched cases
N matched controls
128
Kela drug reimbursment
Cancers of female genital organs
235.6
313.2
296
47
C57.0
ICD-10 Finland
Malignant neoplasm: Fallopian tube
1637.0
257.4
223
*
8461/3-C57.0
ICD-O-3
High grade serous carcinoma of fallopian tube
+∞
210.6
183
*
H02AB02
ATC
dexamethasone; systemic
27.0
172.8
280
316
JAL30
NOMESCO Finland
Omentectomy
87.4
158.4
172
34
A04AA01
ATC
ondansetron; systemic, rectal
26.7
152.4
231
194
A03FA01
ATC
metoclopramide; systemic, rectal
16.6
134.0
314
717
R18
ICD-10 Finland
Ascites
53.7
113.0
134
37
C56.71
ICD-10 Finland
Serous epithelial malignant tumor of the ovary
73.0
112.4
126
25
C57.9
ICD-10 Finland
Malignant neoplasm: Female genital organ, unspecified
477.7
110.1
105
*
B01AB10
ATC
tinzaparin; parenteral
15.9
101.2
183
201
WB113
NOMESCO Finland
Multiple adjuvant cytostatic therapy
19.4
99.8
162
135
WX302
NOMESCO Finland
Thoracal epidural anesthesy
20.4
98.5
156
121
LAF10
NOMESCO Finland
Bilateral salpingo-oophorectomy
19.9
91.8
146
112
LAF16
NOMESCO Finland
Excision of uterus, adnexes and lymph nodes for treatment of ovarian cancer
97.8
90.0
97
13
WD105
NOMESCO Finland
Cystostatic therapy of methastized malignancy
24.1
89.7
132
80
WD125
NOMESCO Finland
Demanding cystostatic therapy of methastized malignancy
19.8
83.5
132
97
C78.6
ICD-10 Finland
Secondary malignant neoplasm of retroperitoneum and peritoneum
59.3
79.1
92
20
WX602
NOMESCO Finland
Repeated or continuing anesthesia shots throug a catheter
14.0
78.0
145
156
C56.00
ICD-10 Finland
Malignant tumor of the ovary without histology
70.4
74.4
84
15
C57.8
ICD-10 Finland
Malignant neoplasm: Overlapping lesion of female genital organs
428.1
72.1
70
*
JEA00
NOMESCO Finland
Appendectomy
16.2
71.0
121
104
D39.10
ICD-10 Finland
Tumor of uncertain or unknown nature in the ovary without histology
21.4
70.5
107
67
L03AA14
ATC
lipegfilgrastim; parenteral
28.5
67.6
93
42
JN4BD
NOMESCO Finland
Extensive body CT
8.8
67.3
168
303
Z51.5
ICD-10 Finland
Palliative care
13.0
65.5
124
133
L03AA13
ATC
pegfilgrastim; parenteral
14.1
58.5
105
98
JAL00
NOMESCO Finland
Biopsy of peritoneum
46.0
56.7
69
18
C574, 8461, 3
ICD-O-3
NA
+∞
56.6
53
*
LCD00
NOMESCO Finland
Hysterectomy
9.7
56.6
126
180
TPH07
NOMESCO Finland
Cathetrisation of artery
8.1
54.4
139
247
JAQ00
NOMESCO Finland
Extensive excision of peritoneum
202.9
52.3
53
*
WD405
NOMESCO Finland
Simple antiboidy therapy of methastized malignancy
19.8
51.3
79
49
N02AA05
ATC
oxycodone; systemic
6.1
49.3
163
405
LX1AE
NOMESCO Finland
Gynecological ultrasound examination as part of clinical examination
7.1
48.8
137
274
JA3AT
NOMESCO Finland
Cathetrisation of abdominal cavity with ultrasound guidance
27.9
48.1
66
28
JAH01
NOMESCO Finland
Laparoscopy
12.3
46.9
89
91
LX1XE
NOMESCO Finland
Other gynecological ultrasound examination
11.6
45.6
89
96
WB121
NOMESCO Finland
Demanding neoadjuvant cytostatic therapy
31.9
40.2
53
19
A04AA55
ATC
palonosetron, combinations; systemic
12.5
39.3
73
70
WB123
NOMESCO Finland
Demanding adjuvant cytostatic therapy
22.7
39.2
57
29
ZX120
NOMESCO Finland
Intravenous
6.6
39.0
112
223
LC2BE
NOMESCO Finland
Transvaginal ultrasound examination of uterus, parametria and lower abdomen
4.1
38.2
221
922
WW500
NOMESCO Finland
Blood transfusion
11.9
37.4
71
71
XF603
NOMESCO Finland
Direct intraarterial blood pressure measurement
11.8
37.1
71
72
R19.0
ICD-10 Finland
Intra-abdominal and pelvic swelling, mass and lump
11.6
36.3
70
72
B01AB05
ATC
enoxaparin; parenteral
3.7
34.2
230
1061
Z51.1
ICD-10 Finland
Chemotherapy session for neoplasm
24.6
34.0
48
22
JAL20
NOMESCO Finland
Excision or destruction of lesion of peritoneum
36.9
33.9
43
13
WB402
NOMESCO Finland
Demanding antibody therapy of primary tumour
45.5
33.8
41
10
JA2AT
NOMESCO Finland
Abdominal puncture with ultrasound guidance
35.9
32.9
42
13
C579, 8461, 3
ICD-O-3
NA
+∞
32.8
31
*
WZC00
NOMESCO Finland
Planning of intervention or health care consultation
3.6
32.2
222
1027
WB401
NOMESCO Finland
Simple antibody therapy of primary tumour
17.1
31.3
50
33
TPX10
NOMESCO Finland
Implantation of vascular injection port
13.1
29.7
53
46
WX402
NOMESCO Finland
General anaesthesia
4.2
29.5
134
428
WZC20
NOMESCO Finland
Multidisciplinary treatment meeting
6.5
26.9
74
134
C56
ICD-10 Finland
Malignant neoplasm of ovary
31.8
26.8
35
12
JAP00
NOMESCO Finland
Freeing of adhesions in the peritoneal cavity
20.4
26.2
39
21
3009
Kela drug reimbursment
Niraparib
100.1
26.0
28
*
JN4AD
NOMESCO Finland
Body CT examination
5.4
26.0
85
191
C56.98
ICD-10 Finland
Malignant tumor of the ovary, indeterminate histology
144.3
25.9
27
*
WD415
NOMESCO Finland
Demanding antibody therapy of methastized malignancy
14.9
25.7
43
32
JAH00
NOMESCO Finland
Laparotomy
13.6
25.2
44
36
1510
Kela drug reimbursment
Niraparib
96.3
25.0
27
*
Z31.5
ICD-10 Finland
Genetic counselling
8.7
24.8
55
72
TJA10
NOMESCO Finland
Laparocentesis
60.0
24.4
28
5
1XC07
NOMESCO Finland
NA
92.5
24.0
26
*
X77
ICPC
Malignant neopl genital female other
49.9
23.6
28
6
JFB46
NOMESCO Finland
Resection of sigmoid colon
20.0
23.5
35
19
WD115
NOMESCO Finland
Multiple cystostatic therapy of methastized malignancy
14.2
23.5
40
31
WC125
NOMESCO Finland
Demanding cytostatic therapy of local tumor recidive
32.3
23.1
30
10
GA4YT
NOMESCO Finland
Puncture of pleura with ultrasound guidance
10.8
22.7
44
45
Z80.3
ICD-10 Finland
Family history of malignant neoplasm of breast
15.6
22.6
37
26
PJD54
NOMESCO Finland
Block dissection of iliac lymph nodes
26.9
22.1
30
12
K56.6
ICD-10 Finland
Other and unspecified intestinal obstruction
9.6
21.8
45
52
PJD53
NOMESCO Finland
Block dissection of aortic lymph nodes
39.6
21.0
26
7
L01XK02
ATC
niraparib; oral
221.0
20.8
21
*
C48.89
ICD-10 Finland
Overall malignant tumor of the peritoneum and retroperitoneum other or unspecified tumor
209.9
19.7
20
*
L02BG04
ATC
letrozole; oral
4.0
19.5
85
251
TPH04
NOMESCO Finland
Cathetrisation of vein
3.1
18.9
126
516
JN3BD
NOMESCO Finland
Extensive abdominal CT
3.9
18.9
86
264
JMA10
NOMESCO Finland
Transabdominal total splenectomy
31.8
18.5
24
8
JGB03
NOMESCO Finland
Partial proctectomy with partial excision of mesorectum
69.9
17.9
20
*
389
Kela drug reimbursment
Olaparib
+∞
16.8
16
*
1511
Kela drug reimbursment
Olaparib
+∞
16.8
16
*
8441/3-C57.0
ICD-O-3
Serous carcinoma, NOS, of fallopian tube
+∞
16.8
16
*
JF1AB
NOMESCO Finland
Passage examination of small bowell with X-ray
17.3
16.8
26
16
WX306
NOMESCO Finland
Lumbar epidural anesthesy
5.5
16.7
51
104
C79.8
ICD-10 Finland
Secondary malignant neoplasm of other specified sites
6.5
16.6
44
75
XW4AT
NOMESCO Finland
Biopsy of other inner organ with ultrasound guidance
42.0
16.5
20
5
WC105
NOMESCO Finland
Simple cytostatic therapy of local tumor recidive
30.0
15.3
20
7
WX404
NOMESCO Finland
Intravenous generell anesthesy
2.6
15.3
139
679
TLE20
NOMESCO Finland
Transvaginal puncture of cul-de-sac
59.0
14.9
17
*
WB103
NOMESCO Finland
Simple adjuvant cytostatic therapy
5.4
14.7
45
92
JBA10
NOMESCO Finland
Transabdominal biopsy or excision of lesion of diaphragm
83.2
14.7
16
*
L03AA02
ATC
filgrastim; parenteral
6.8
14.7
37
59
J90
ICD-10 Finland
Pleural effusion, not elsewhere classified
7.5
14.4
34
49
JFB00
NOMESCO Finland
Partial resection of small intestine
12.6
14.3
25
21
WB111
NOMESCO Finland
Multiple neoadjuvant cytostatic therapy
55.4
13.9
16
*
GA4AT
NOMESCO Finland
Cathetrisation of pleural cavity with ultrasound guidance
14.3
13.9
23
17
XLD00
NOMESCO Finland
Sytologyspecimen from mouth of uterus
3.0
13.5
87
341
JAL01
NOMESCO Finland
Laparoscopic biopsy of peritoneum
22.1
13.5
19
9
K56.7
ICD-10 Finland
Ileus, unspecified
10.2
13.4
26
27
LC2AE
NOMESCO Finland
Ultrasound examination of uterus and parametria
3.1
13.2
79
295
KBV02
NOMESCO Finland
Cystoscopic insertion of stent into ureter
7.6
13.0
30
42
N02AB03
ATC
fentanyl; nasal, sublingual, transdermal
5.0
12.4
40
87
JN3AD
NOMESCO Finland
Abdominal CT examination
3.6
12.2
58
182
N13.3
ICD-10 Finland
Other and unspecified hydronephrosis
8.3
12.0
26
33
166
Kela drug reimbursment
Dalteparin and tinzaparin (treatment for more than 6 months)
13.1
11.8
20
16
LCA06
NOMESCO Finland
Biopsy of endometrium
2.6
11.7
95
426
XX9BW
NOMESCO Finland
Submitting image material and/or investigation material to authority or other institution
11.6
11.7
21
19
8380/3-C57.0
ICD-O-3
Endometrioid adenocarcinoma, NOS, of fallopian tube
+∞
11.5
11
*
D39.0
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour: Uterus
14.4
11.1
18
13
J94.8
ICD-10 Finland
Other specified pleural conditions
8.6
11.0
23
28
GD1UA
NOMESCO Finland
Thorax X-ray examination outside radiological department
2.7
10.6
80
340
GAE03
NOMESCO Finland
Suture of chest wall
+∞
10.5
10
*
8140/3-C57.0
ICD-O-3
Adenocarcinoma, NOS, of fallopian tube
+∞
10.5
10
*
A79
ICPC
Malignancy NOS
10.0
10.4
20
21
JAL31
NOMESCO Finland
Laparoscopic omentectomy
19.4
10.3
15
8
SPAT1109
SPAT
Analgesia with portable analgesic pump
24.1
10.3
14
6
TPH15
NOMESCO Finland
Insertion of central venous catheter through external or internal jugular vein
4.0
10.2
40
107
D39.9
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour: Female genital organ, unspecified
41.2
10.0
12
*
GD1AA
NOMESCO Finland
Thorax X-ray examination
2.0
9.6
204
1388
C76.3
ICD-10 Finland
Malignant neoplasm of other and ill-defined sites: Pelvis
102.4
9.5
10
*
C56.73
ICD-10 Finland
Endomeroid epithelial carcinoma of the ovary
30.8
9.5
12
*
L01XK01
ATC
olaparib; oral
+∞
9.4
9
*
8000/3-C57.9
ICD-O-3
Neoplasm, malignant of female genital tract, NOS
+∞
9.4
9
*
L01XX46
ATC
[U] olaparib; oral
+∞
9.4
9
*
8140/3-C57.9
ICD-O-3
Adenocarcinoma, NOS, of female genital tract, NOS
+∞
9.4
9
*
A02BC02
ATC
pantoprazole; systemic
2.1
9.4
300
2371
ZXC40
NOMESCO Finland
Use of ultrasound
11.8
9.1
16
14
A04AA02
ATC
granisetron; systemic, transdermal
3.0
9.1
52
187
D70.82
ICD-10 Finland
Drug-induced neutropenia
5.7
9.1
25
46
LAF11
NOMESCO Finland
Laparoscopic bilateral salpingo-oophorectomy
2.9
9.0
55
205
WF049
NOMESCO Finland
Radiotherapy of metastasis
4.8
9.0
29
64
R10.4
ICD-10 Finland
Other and unspecified abdominal pain
1.9
8.5
168
1098
JFB30
NOMESCO Finland
Right hemicolectomy
7.6
8.5
19
26
A04AA03
ATC
tropisetron; systemic
28.2
8.5
11
*
C77.8
ICD-10 Finland
Secondary and unspecified malignant neoplasm: Lymph nodes of multiple regions
20.6
8.5
12
6
B03XA02
ATC
darbepoetin alfa; parenteral
8.1
8.5
18
23
C48.20
ICD-10 Finland
Malignant tumor in unspecified localization in the peritoneum without histology
+∞
8.4
8
*
C76.2
ICD-10 Finland
Malignant neoplasm of other and ill-defined sites: Abdomen
+∞
8.4
8
*
JFF10
NOMESCO Finland
Loop enterostomy
17.6
8.1
12
7
C78.2
ICD-10 Finland
Secondary malignant neoplasm of pleura
34.1
8.1
10
*
WC115
NOMESCO Finland
Cytostatic therapy of local tumor recidive with multiple drugs
34.1
8.1
10
*
GA1AE
NOMESCO Finland
Ultrasound examination of thorax
6.1
8.1
21
36
D39.19
ICD-10 Finland
Tumor of uncertain or unknown nature in the ovary with unspecified histology
10.3
8.1
15
15
LC2DE
NOMESCO Finland
Demanding ultrsound examination of uterus, parametrium and lower part of abdomen with speciel methods
4.0
8.1
31
82
8461/3-C56.9
ICD-O-3
High grade serous carcinoma of ovary
15.4
7.8
12
8
JFA80
NOMESCO Finland
Suture of colon
45.9
7.7
9
*
C56.79
ICD-10 Finland
Other epithelial carcinoma of the ovary
18.8
7.6
11
6
PJD44
NOMESCO Finland
Excision of iliac lymph nodes
25.6
7.6
10
*
C80.90
ICD-10 Finland
Malignant tumor without specified localization without histology
81.5
7.4
8
*
GAA10
NOMESCO Finland
Intercostal insertion of pleural drainage tube
7.1
7.4
17
25
N02BE01
ATC
paracetamol; systemic, rectal
2.5
7.3
369
3288
JJA40
NOMESCO Finland
Excision of lesion of liver
+∞
7.3
7
*
LAF17
NOMESCO Finland
Laparoscopic excision of uterus, adnexes and lymph nodes for treatment of ovarian cancer
+∞
7.3
7
*
ZXK00
NOMESCO Finland
Conversion from percutaneous endoscopic to open procedure
16.1
7.3
11
7
R2110
NOMESCO Finland
Giving the first information
3.0
7.2
41
146
FB1BD
NOMESCO Finland
Extensive CT examination of arteria pulmonalis
2.7
7.2
49
197
Z93.3
ICD-10 Finland
Colostomy status
10.3
7.1
13
13
A49.9
ICD-10 Finland
Bacterial infection, unspecified
2.4
7.1
60
273
JN3AE
NOMESCO Finland
Abdominal ultrasound examination
2.3
6.9
66
317
WX704
NOMESCO Finland
Intubation
3.0
6.8
39
140
R50.9
ICD-10 Finland
Fever, unspecified
2.3
6.8
65
313
GAE06
NOMESCO Finland
Excision of lesion of chest wall
40.8
6.8
8
*
JFF30
NOMESCO Finland
Other colostomy
40.8
6.8
8
*
C78.8
ICD-10 Finland
Secondary malignant neoplasm of other and unspecified digestive organs
23.0
6.7
9
*
Z80.4
ICD-10 Finland
Family history of malignant neoplasm of genital organs
23.0
6.7
9
*
JFG40
NOMESCO Finland
Revision of enterostomy or colostomy without laparotomy
23.0
6.7
9
*
JFF23
NOMESCO Finland
Transversostomy
8.9
6.6
13
15
C48.00
ICD-10 Finland
Malignant tumor of the retroperitoneal space without histology
70.9
6.4
7
*
L01XX54
ATC
[U] niraparib; oral
70.9
6.4
7
*
KBV10
NOMESCO Finland
Removal of stent from ureter
14.6
6.4
10
7
ZX100
NOMESCO Finland
Oral
9.5
6.3
12
13
LEB00
NOMESCO Finland
Biopsy of vagina
4.9
6.3
19
40
XX1XW
NOMESCO Finland
Extensive written report from radiologist
5.2
6.3
18
36
JJB10
NOMESCO Finland
Atypcal resection of liver
27.1
6.2
8
*
R4190
NOMESCO Finland
Nutritional therapy
4.4
6.2
21
50
WX725
NOMESCO Finland
Noninvasive ventilation
3.4
6.1
28
87
Z51.88
ICD-10 Finland
Other specified medical care
5.0
6.1
18
37
D25
ICPC
Abdominal distension
5.0
6.1
18
37
M54.5
ICD-10 Finland
Low back pain
0.5
6.1
57
996
GAA96
NOMESCO Finland
Other open or percutaneous drainage of pleural cavity
12.8
6.1
10
8
D39.11
ICD-10 Finland
Epithelial tumor of uncertain nature in the ovary
10.2
6.1
11
11
D39.1
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour: Ovary
10.2
6.1
11
11
WVA20
NOMESCO Finland
Medicine administration
6.2
6.1
15
25

LabWAS

↥
OMOP Concept
People with measurements
Mean N measurements
Mean measured value
(ID) Name
N Cases
N Controls
OR
-log10(p)
cases
controls
unit
cases
controls
-log10(p)
N cases
N controls
(4281824)
176
63
46.10
275.21
1.3
1.0
—
—
—
0
0
(3003785) Carcinoembryonic Ag [Mass/volume] in Serum or Plasma
238
477
9.76
129.94
1.8
3.8
ug/l
2.7
10.0
3.63
149
388
(4035726)
186
389
7.58
93.54
1.5
1.4
—
—
—
0
0
(3022914) Cancer Ag 19-9 [Units/volume] in Serum or Plasma
102
165
7.76
63.47
2.0
2.7
u/ml
26.0
998.3
0.64
84
146
(3033799) Differential panel - Peritoneal fluid
38
10
41.52
62.03
1.4
1.3
—
—
—
0
0
(3044007) Cell count panel - Peritoneal fluid
37
11
36.66
58.41
1.4
2.3
—
—
—
0
0
(3023368) Bacteria identified in Blood by Culture
257
1015
4.72
57.04
5.1
3.8
—
—
—
0
0
(3009613) Erythrocytes [#/volume] in Peritoneal fluid
36
11
35.58
56.35
1.3
2.3
e6/l
2514.8
172527.5
—
17
6
(3024561) Albumin [Mass/volume] in Serum or Plasma
353
1830
5.83
53.61
7.6
4.0
g/l
31.6
35.4
22.70
347
1682
(3001079) Blood group antibody screen [Presence] in Serum or Plasma
345
1863
5.05
46.76
5.6
3.7
—
—
—
0
0
(3013650) Neutrophils [#/volume] in Blood by Automated count
382
2296
6.27
43.46
31.6
8.8
e9/l
3.4
4.0
6.42
344
2008
(3044640) Blood type and Crossmatch panel - Blood
259
1260
3.59
37.88
3.2
2.2
—
—
—
0
0
(40768806) Pleura Pathology biopsy report
41
41
10.93
36.81
1.5
1.5
—
—
—
0
0
(3003396) Base excess in Arterial blood by calculation
135
445
3.94
35.65
5.7
6.4
mmol/l
0.7
1.5
1.70
120
359
(3043405) Microscopic observation [Identifier] in Specimen by Non-gynecological cytology method
32
29
11.83
30.56
1.1
1.2
—
—
—
0
0
(3032080) INR in Blood by Coagulation assay
282
1637
3.04
27.26
6.7
8.6
inr
1.1
1.2
1.90
83
456
(3000991) Gas panel - Venous blood
96
302
3.79
26.46
5.0
6.7
—
—
—
0
0
(40758558) Short blood count panel - Blood
209
1049
2.90
26.20
22.1
6.7
—
—
—
0
0
(46236098) ABO and Rh group [Type] in Blood by Confirmatory method
195
977
2.80
24.05
3.0
2.1
—
—
—
0
0
(3042936) Bacteria identified in Isolate by Culture
136
566
3.04
23.63
2.0
1.9
—
—
—
0
0
(3020427) Coagulation factor X inhibitor [Units/volume] in Platelet poor plasma by Coagulation assay
50
107
5.15
22.57
2.4
2.5
u/ml
0.3
0.4
0.74
21
67
(3029287) Urinalysis microscopic panel [#/volume] - Urine by Automated count
246
1422
2.67
22.35
3.9
3.2
—
—
—
0
0
(3023199) Leukocytes [#/volume] in Pleural fluid
33
48
7.35
21.94
1.5
1.2
e6/l
1369.3
1283.1
0.08
26
33
(3028308) Erythrocytes [#/volume] in Pleural fluid
31
42
7.87
21.91
1.6
1.2
e6/l
11879.7
212006.0
0.65
18
22
(3045788) Cell count panel - Pleural fluid
31
42
7.87
21.91
1.5
1.2
—
—
—
0
0
(3026008) Bacteria identified in Urine by Culture
258
1555
2.61
21.07
3.4
3.4
—
—
—
0
0
(3013721) Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma
215
1195
2.57
20.73
8.8
2.7
u/l
65.2
29.3
0.53
209
1127
(3012441) Differential panel - Pleural fluid
29
39
7.89
20.60
1.7
1.3
—
—
—
0
0
(3018095) Leukocytes [#/volume] in Urine
237
1416
2.47
19.07
6.9
3.9
e6/l
64.6
101.4
0.75
168
983
(3003694) ABO and Rh group [Type] in Blood
174
905
2.53
18.92
1.4
1.3
—
—
—
0
0
(3002582) Erythrocytes [#/volume] in Urine
210
1193
2.46
18.82
3.7
3.3
e6/l
36.5
47.5
0.27
158
901
(40768804) Tissue Pathology biopsy report
266
1690
2.47
18.47
2.6
2.2
—
—
—
0
0
(36304419) Bacteria [Presence] in Urine
197
1096
2.45
18.38
3.4
3.1
—
—
—
0
0
(3004410) Hemoglobin A1c/Hemoglobin.total in Blood
293
3672
0.39
18.01
4.8
6.2
mmol/mol
39.8
40.0
0.10
259
3333
(36305247) Microscopic observation [Identifier] in Isolate by Gram stain
46
111
4.51
17.92
1.9
1.4
—
—
—
0
0
(3015377) Calcium [Moles/volume] in Serum or Plasma
251
1568
2.41
17.89
7.0
3.4
mmol/l
2.3
2.4
1.91
241
1324
(3005772) Bilirubin.conjugated [Moles/volume] in Serum or Plasma
104
429
2.87
17.85
2.6
2.2
umol/l
7.7
7.7
0.01
91
363
(3031040) Bacteria [#/volume] in Urine by Automated count
365
2733
3.04
17.42
6.8
5.2
e6/l
235.6
3431.9
—
7
41
(3030467) Casts [#/volume] in Urine by Automated count
195
1123
2.33
16.35
3.5
3.1
e6/l
0.7
0.5
0.34
145
840
(3019060) Gas panel - Arterial blood
73
260
3.17
16.14
5.6
4.3
—
—
—
0
0
(3009261) Glucose [Presence] in Urine by Test strip
291
1999
2.36
15.87
8.9
4.3
estimate
0.0
0.0
0.50
67
373
(3021601) Nitrite [Presence] in Urine by Test strip
289
1985
2.35
15.68
12.5
5.7
estimate
0.0
0.0
0.00
63
374
(3035995) Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma
396
3168
3.66
15.59
13.6
7.2
u/l
90.5
78.3
5.79
388
2933
(3000515) Antithrombin actual/normal in Platelet poor plasma by Chromogenic method
39
95
4.41
14.98
1.6
2.1
%
90.2
94.6
0.50
39
89
(3016417) Amylase.pancreatic [Enzymatic activity/volume] in Serum or Plasma
93
397
2.71
14.74
2.4
2.2
u/l
31.5
33.2
0.15
83
331
(3013742) Prealbumin [Mass/volume] in Serum or Plasma
91
387
2.71
14.51
1.8
1.9
g/l
0.2
0.2
1.22
86
367
(3051552) Clostridioides difficile toxin genes [Presence] in Stool by NAA with probe detection
77
300
2.90
14.49
1.7
1.5
—
—
—
0
0
(3001308) Cholesterol in LDL [Moles/volume] in Serum or Plasma
338
3922
0.39
13.89
4.1
5.5
mmol/l
2.9
2.8
2.32
290
3530
(3029879) Epithelial cells.squamous [#/volume] in Urine by Automated count
125
633
2.37
13.71
3.5
2.9
e6/l
3.7
3.8
0.04
62
316
(3023602) Cholesterol in HDL [Moles/volume] in Serum or Plasma
322
3798
0.42
13.07
3.4
4.8
mmol/l
1.6
1.6
0.40
283
3406
(3021347) Calcium.ionized [Moles/volume] in Serum or Plasma
286
2040
2.16
12.98
5.6
5.2
mmol/l
1.2
1.2
16.23
273
1822
(40762366) Oxygen capacity [Volume Fraction] in Arterial blood
56
195
3.15
12.77
6.5
7.8
—
—
—
0
0
(3011397) Hemoglobin [Presence] in Urine by Test strip
166
970
2.15
12.70
8.1
4.1
—
—
—
0
0
(3030306) Epithelial cells.non-squamous [#/volume] in Urine by Automated count
130
696
2.24
12.34
3.3
2.7
e6/l
1.5
1.3
0.15
69
380
(42870588) Differential panel, method unspecified - Blood
208
1336
2.06
12.26
6.2
5.4
—
—
—
0
0
(3019900) Cholesterol [Moles/volume] in Serum or Plasma
329
3827
0.43
11.86
3.5
4.8
mmol/l
5.0
4.8
2.21
286
3454
(3047181) Lactate [Moles/volume] in Blood
39
114
3.66
11.68
6.0
6.1
mmol/l
1.3
1.3
0.03
34
104
(3013826) Glucose [Moles/volume] in Serum or Plasma
310
2331
2.14
11.59
5.9
4.4
mmol/l
6.7
6.6
0.42
302
2182
(3005702) Mycobacterium sp identified in Specimen by Organism specific culture
31
79
4.15
11.22
1.2
1.3
—
—
—
0
0
(3016771) Amylase [Enzymatic activity/volume] in Serum or Plasma
198
1279
2.00
11.21
4.5
2.2
u/l
55.1
56.7
0.23
189
1149
(3037467) Urinalysis macro (dipstick) panel - Urine
349
2772
2.29
11.01
10.2
4.8
—
—
—
0
0
(3019069) Monocytes/100 leukocytes in Blood
257
1834
1.97
10.74
6.9
5.9
%
8.7
8.4
0.56
246
1691
(3001604) Monocytes [#/volume] in Blood
267
1931
1.98
10.73
7.1
5.4
e9/l
0.6
0.6
0.49
228
1647
(3006315) Basophils [#/volume] in Blood
268
1941
1.98
10.72
7.1
5.4
e9/l
0.0
0.0
1.39
228
1655
(3022096) Basophils/100 leukocytes in Blood
249
1769
1.95
10.42
6.8
5.6
%
0.6
0.7
3.70
238
1621
(3013115) Eosinophils [#/volume] in Blood
273
2007
1.96
10.25
7.2
5.7
e9/l
0.1
0.2
6.34
235
1741
(3019198) Lymphocytes [#/volume] in Blood
268
1963
1.94
10.12
7.2
5.4
e9/l
1.5
1.9
5.41
233
1706
(3002030) Lymphocytes/100 leukocytes in Blood
257
1857
1.93
10.10
6.8
5.7
%
22.9
28.1
8.60
245
1697
(3018171) Choriogonadotropin [Units/volume] in Serum or Plasma
17
28
6.28
9.99
1.5
1.9
u/l
2.9
9994.6
—
10
9
(3006504) Eosinophils/100 leukocytes in Blood
253
1826
1.92
9.90
6.8
5.5
%
2.2
2.8
2.36
243
1674
(3016431) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Serum or Plasma
290
2198
1.95
9.69
6.0
6.0
mmol/l
1.2
1.2
17.29
261
1850
(3000850) Epithelial cells [#/volume] in Urine
141
844
1.99
9.62
2.7
2.6
e6/l
8.8
6.8
0.49
125
753
(3021589) Normoblasts [#/volume] in Blood
241
1741
1.86
9.10
16.9
9.4
e9/l
0.0
0.0
1.18
191
1421
(3035350) Ketones [Presence] in Urine by Test strip
264
1963
1.87
9.09
9.5
4.3
estimate
0.0
0.0
0.00
62
378
(3038288) Influenza virus B RNA [Presence] in Specimen by NAA with probe detection
90
465
2.18
9.06
1.6
1.8
—
—
—
0
0
(3020891) Body temperature
43
157
2.93
9.00
5.5
4.1
—
—
—
0
0
(3007853) Bacteria identified in Skin by Aerobe culture
83
424
2.18
8.56
1.4
1.7
—
—
—
0
0
(3018010) Neutrophils/100 leukocytes in Blood
248
1834
1.81
8.43
6.4
5.5
%
60.8
57.0
3.29
236
1691
(3043924) Respiratory syncytial virus RNA [Identifier] in Specimen by NAA with probe detection
88
464
2.12
8.37
1.6
1.8
—
—
—
0
0
(3003458) Phosphate [Moles/volume] in Serum or Plasma
92
495
2.09
8.29
3.2
3.9
mmol/l
1.0
1.1
0.30
86
442
(43055361) Metamyelocytes/Leukocytes [Pure number fraction] in Blood by Manual count
13
20
6.67
8.11
1.5
3.7
—
—
—
0
0
(3048773) Triglyceride [Moles/volume] in Serum or Plasma --fasting
317
3654
0.52
8.07
3.1
4.2
mmol/l
1.3
1.3
1.48
278
3238
(3026782) Osmolality of Urine
128
793
1.87
7.62
2.8
2.8
mosm/kgh2o
513.1
495.5
0.47
106
682
(3035880) pH of Pleural fluid
14
25
5.75
7.59
1.3
1.1
—
—
—
0
0
(3018251) Fasting glucose [Moles/volume] in Serum or Plasma
344
3849
0.50
7.45
4.4
5.0
mmol/l
5.9
5.9
0.62
308
3428
(3029536) Hepatitis C virus RNA [Units/volume] (viral load) in Specimen by NAA with probe detection
12
9
13.66
7.42
1.0
1.0
—
—
—
0
0
(586526) SARS-CoV-2 (COVID-19) RNA [Presence] in Nasopharynx by NAA with probe detection
52
232
2.41
7.33
1.6
1.4
—
—
—
0
0
(3025839) Triglyceride [Moles/volume] in Serum or Plasma
66
1191
0.47
7.31
1.4
1.6
mmol/l
1.4
1.3
0.49
58
977
(3044889) 12 lead EKG panel
339
2845
1.85
6.71
4.6
4.0
—
—
—
0
0
(3018006) Microscopic observation [Identifier] in Cervix by Cyto stain.thin prep
126
804
1.80
6.70
1.2
1.3
—
—
—
0
0
(3043362) Influenza virus B Ag [Presence] in Nasopharynx by Immunoassay
26
85
3.19
6.58
1.4
1.3
—
—
—
0
0
(3046524) Influenza virus A Ag [Presence] in Nasopharynx by Immunoassay
26
85
3.19
6.58
1.4
1.3
—
—
—
0
0
(3052851) Hemolysis interference index of Serum or Plasma
33
127
2.73
6.29
2.1
3.2
—
—
—
0
0
(3018418) pH of Serum or Plasma
190
1380
1.67
6.25
3.1
3.6
ph
7.4
7.4
0.14
27
254
(3021337) Troponin I.cardiac [Mass/volume] in Serum or Plasma
121
781
1.76
6.12
3.2
4.2
ng/l
45.9
282.8
2.13
92
633
(3005715) Vancomycin [Mass/volume] in Serum or Plasma
15
35
4.40
6.07
7.7
5.4
mg/l
11.3
13.2
1.00
15
30
(42868674) Cholesterol in HDL/Cholesterol.total [Molar ratio] in Serum or Plasma
22
574
0.35
5.85
3.4
4.8
%
29.1
34.3
2.47
17
348
(3044938) Influenza virus A RNA [Presence] in Specimen by NAA with probe detection
103
642
1.79
5.84
1.7
1.8
—
—
—
0
0
(3019902) Methicillin resistant Staphylococcus aureus [Presence] in Specimen by Organism specific culture
76
434
1.91
5.68
3.8
3.5
—
—
—
0
0
(3014162) Mycobacterium tuberculosis DNA [Presence] in Specimen by NAA with probe detection
30
118
2.66
5.50
2.1
2.3
—
—
—
0
0
(3020460) C reactive protein [Mass/volume] in Serum or Plasma
414
3801
2.69
5.43
26.6
14.6
mg/l
42.0
21.5
21.62
399
3008
(3002256) Pathology report gross observation
83
504
1.80
5.10
1.1
1.3
—
—
—
0
0
(44790049)
13
32
4.16
4.93
1.2
1.6
—
—
—
0
0
(44790048)
13
32
4.16
4.93
1.2
1.6
—
—
—
0
0
(44790047)
13
32
4.16
4.93
1.2
1.6
—
—
—
0
0
(44806118)
13
32
4.16
4.93
1.2
1.6
—
—
—
0
0
(3029937) Albumin [Presence] in Urine by Test strip
148
1067
1.59
4.72
9.4
4.7
estimate
0.0
0.0
0.00
62
374
(3019225) pH of Specimen
18
468
0.36
4.72
3.0
3.8
—
—
—
0
0
(3020059) Calcium [Moles/volume] corrected for albumin in Serum or Plasma
127
888
1.61
4.59
3.5
2.9
mmol/l
2.5
2.5
5.04
115
772
(3009201) Thyrotropin [Units/volume] in Serum or Plasma
336
3700
0.60
4.49
5.8
5.6
mu/l
2.0
2.0
0.48
303
3323
(1761868) Lipid panel - Serum or Plasma
75
1153
0.58
4.49
2.1
3.2
—
—
—
0
0
(40771025) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma
144
1891
0.64
4.41
2.0
2.3
nmol/l
78.8
80.9
0.35
127
1647
(3019601) Blood group antibody investigation [Interpretation] in Plasma or RBC
11
26
4.31
4.38
2.3
2.0
—
—
—
0
0
(3008486) Thyroxine (T4) free [Moles/volume] in Serum or Plasma
284
3230
0.66
4.12
4.9
4.6
pmol/l
15.1
15.1
0.07
259
2885
(40761535) Cells panel - Urine sediment
57
333
1.82
3.96
6.8
3.5
—
—
—
0
0
(40763571) Iron/Transferrin [Ratio] in Serum or Plasma
82
539
1.64
3.75
2.1
2.2
%
20.4
20.9
0.13
67
450
(3051714) Fibrin D-dimer FEU [Mass/volume] in Platelet poor plasma
125
912
1.52
3.64
1.7
1.6
mg/l
2.5
1.1
4.15
107
712
(40761536) Microorganisms panel - Urine sediment
57
342
1.77
3.63
13.0
4.4
—
—
—
0
0
(3041942) Cyclic citrullinated peptide Ab [Units/volume] in Serum
45
751
0.55
3.54
1.1
1.3
u/ml
1.1
13.8
5.19
17
252
(3021614) Rheumatoid factor [Units/volume] in Serum or Plasma
47
774
0.56
3.53
1.1
1.3
iu/ml
9.3
36.2
8.76
13
253
(3013512) EKG study
95
1299
0.66
3.26
3.5
3.8
—
—
—
0
0
(40760892) CBC W Ordered Manual Differential panel - Blood
109
793
1.50
3.18
7.7
4.7
—
—
—
0
0
(3021447) Carbon dioxide [Partial pressure] in Venous blood
57
361
1.67
3.01
3.3
2.8
kpa
5.6
5.9
1.27
57
351
(3017143) Hepatitis C virus Ab [Presence] in Serum
47
287
1.71
2.84
1.2
1.3
—
—
—
0
0
(3009306) Alpha-1-Fetoprotein [Mass/volume] in Serum or Plasma
6
10
6.07
2.70
4.0
2.0
—
—
—
0
0
(3040853) Adenovirus DNA [Identifier] in Specimen by NAA with probe detection
18
80
2.30
2.64
1.1
1.6
—
—
—
0
0
(3024891) Influenza virus A+B Ag [Presence] in Specimen
19
87
2.24
2.61
1.4
1.2
—
—
—
0
0
(3012544) pH of Venous blood
56
367
1.60
2.60
3.3
2.9
—
—
—
0
0
(40757494) Bilirubin.total [Moles/volume] in Blood
8
21
3.86
2.47
1.6
2.6
—
—
—
0
0
(3024354) Oxygen [Partial pressure] in Venous blood
47
299
1.64
2.46
2.8
2.3
kpa
4.3
4.3
0.00
47
291
(3019150) Specific gravity of Urine by Refractometry
112
858
1.41
2.45
6.3
4.8
kg/l
1.0
1.0
0.40
12
126
(43054903) Holo-transcobalamin II [Moles/volume] in Serum
149
1809
0.73
2.44
2.1
2.0
pmol/l
94.3
99.6
0.84
92
797
(40769539) Bacteria identified based on 16S rRNA gene [Identifier] in Specimen by Sequencing
18
83
2.22
2.44
1.5
1.6
—
—
—
0
0
(3002482) Mycoplasma pneumoniae DNA [Presence] in Specimen by NAA with probe detection
14
58
2.46
2.39
1.0
1.6
—
—
—
0
0
(3044927) Protein electrophoresis panel - Urine
0
59
0.00
2.26
0.0
1.1
—
—
—
0
0
(3015399) Transferrin receptor.soluble [Mass/volume] in Serum or Plasma
126
998
1.37
2.24
1.7
2.2
mg/l
2.8
3.3
1.44
111
835
(3021879) Hepatitis B virus core Ab [Presence] in Serum
33
196
1.74
2.23
1.1
1.2
—
—
—
0
0
(3020682) Albumin/Creatinine [Ratio] in Urine
104
1318
0.72
2.19
3.7
3.9
mg/mmol
24.5
5.1
1.68
60
724
(21494755) Public health laboratory ask at order entry panel
6
168
0.35
2.18
1.2
1.4
—
—
—
0
0
(3028531) Enolase.neuron specific [Mass/volume] in Serum or Plasma
9
30
3.04
2.16
1.4
1.3
ug/l
43.5
17.8
—
9
30
(3002434) Lupus erythematosus deoxynucleoproteins IgG Ab [Units/volume] in Serum by Immunoassay
5
145
0.34
2.05
1.4
1.5
—
—
—
0
0
(40761511) CBC panel - Blood by Automated count
410
3926
1.72
2.01
28.6
13.9
—
—
—
0
0
(3032035) Polymorphonuclear cells/100 leukocytes in Blood
17
84
2.07
1.98
9.4
3.4
%
62.4
61.2
0.13
17
84
(3009542) Hematocrit [Volume Fraction] of Blood
356
3318
1.39
1.96
38.6
16.4
%
35.5
38.5
10.23
260
2135
(36031861) Influenza virus A and B and SARS-CoV-2 (COVID-19) and Respiratory syncytial virus RNA panel - Respiratory system specimen by NAA with probe detection
38
244
1.61
1.95
1.7
1.6
—
—
—
0
0
(3009508) Creatinine [Moles/volume] in Urine
102
1272
0.74
1.89
3.1
3.0
mmol/l
5.8
6.1
0.49
84
1042
(43055120) Cytomegalovirus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection
13
59
2.24
1.86
1.2
5.8
—
143.5
—
0
6
(40763086) Leukocyte esterase [Presence] in Urine by Automated test strip
174
1481
1.29
1.83
9.6
4.6
—
—
—
0
0
(3017181) Myelocytes/100 leukocytes in Blood
50
350
1.48
1.77
3.4
3.9
%
1.2
1.1
0.14
30
90
(3042194) Human metapneumovirus RNA [Presence] in Specimen by NAA with probe detection
17
89
1.95
1.72
1.1
1.6
—
—
—
0
0
(4146454)
0
47
0.00
1.71
0.0
2.6
—
—
—
0
0
(3019309) Folate [Moles/volume] in Red Blood Cells
64
846
0.71
1.71
1.7
1.7
nmol/l
1217.1
1223.0
0.02
51
598
(3004588) Protein electrophoresis panel - Serum or Plasma
20
340
0.57
1.70
2.2
2.5
—
—
—
0
0
(3049717) Cytology report of Urine Cyto stain
21
119
1.80
1.69
2.0
2.5
—
—
—
0
0
(3012516) Albumin [Mass/volume] in Urine
102
1253
0.76
1.68
2.9
3.1
mg/l
98.3
319.3
0.99
59
684
(3008909) Norovirus RNA [Presence] in Stool by NAA with probe detection
22
127
1.77
1.67
1.2
1.2
—
—
—
0
0
(3033319) Streptococcus pyogenes Ag [Presence] in Throat
8
175
0.45
1.61
1.3
1.2
—
—
—
0
0
(3019284) Hepatitis B virus surface Ag [Presence] in Serum
45
317
1.47
1.56
1.2
1.3
—
—
—
0
0
(3006418) Campylobacter sp identified in Tissue by Organism specific culture
23
138
1.70
1.55
1.2
1.1
—
—
—
0
0
(44816559) Phosphatidylethanol [Mass/volume] in Blood
0
44
0.00
1.52
0.0
1.1
—
—
—
0
0
(3024889) Methemoglobin/Hemoglobin.total in Venous blood
29
187
1.59
1.50
3.6
2.1
%
0.6
0.6
0.53
29
179
(3030905) Polymorphonuclear cells [#/volume] in Blood
15
80
1.91
1.46
10.0
3.1
e9/l
5.0
4.6
0.08
15
80
(3025023) Rhinovirus RNA [Presence] in Specimen by NAA with probe detection
7
28
2.52
1.45
1.1
1.5
—
—
—
0
0
(3037522) Nuclear Ab [Titer] in Serum
39
542
0.69
1.39
1.2
1.3
titre
210.0
631.4
—
8
135
(3051651) Icteric interference index of Serum or Plasma
6
23
2.63
1.37
1.0
2.9
—
—
—
0
0
(3006653) Thiamine [Moles/volume] in Blood
5
17
2.96
1.36
1.0
1.4
nmol/l
133.4
129.3
—
5
17
(3028300) Cannabinoids [Presence] in Urine
0
37
0.00
1.35
0.0
1.3
—
—
—
0
0
(3027008) Opiates [Presence] in Urine
0
37
0.00
1.35
0.0
1.3
—
—
—
0
0
(3027238) Thyroperoxidase Ab [Units/volume] in Serum or Plasma
17
276
0.60
1.26
1.1
1.2
iu/ml
47.2
145.4
—
6
108
(46236952) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD)
45
333
1.39
1.23
7.7
2.5
ml/min/173m2
62.1
63.9
0.13
25
132
(3014765) Yersinia sp identified in Stool by Organism specific culture
22
140
1.60
1.22
1.2
1.1
—
—
—
0
0
(1616796) Gas panel - Central venous blood
13
71
1.86
1.20
3.5
3.9
—
—
—
0
0
(3003510) Neisseria gonorrhoeae DNA [Presence] in Urine by NAA with probe detection
6
127
0.47
1.18
1.2
1.4
—
—
—
0
0
(43054914) Glucose tolerance 2 hours panel - Serum or Plasma
25
365
0.67
1.17
1.6
1.6
—
—
—
0
0
(42529406) Shigella sp [Presence] in Stool by Culture
22
142
1.58
1.16
1.2
1.1
—
—
—
0
0
(3011951) Aspergillus fumigatus IgE Ab [Units/volume] in Serum
0
33
0.00
1.16
0.0
1.1
—
1.9
—
0
11
(3016879) Cocaine [Presence] in Urine
0
36
0.00
1.14
0.0
1.3
—
—
—
0
0
(3027944) Amphetamines [Presence] in Urine
0
36
0.00
1.14
0.0
1.3
—
—
—
0
0
(3000764) Benzodiazepines [Presence] in Urine
0
36
0.00
1.14
0.0
1.3
—
—
—
0
0
(3019832) Treponema pallidum Ab [Presence] in Serum
5
114
0.43
1.14
1.0
1.3
—
—
—
0
0
(3013707) Erythrocyte sedimentation rate by Westergren method
284
3027
0.82
1.13
2.9
4.5
mm/h
20.5
13.9
6.08
259
2742
(3016881) Enterovirus RNA [Presence] in Specimen by NAA with probe detection
7
30
2.35
1.13
1.1
1.4
—
—
—
0
0
(3012477) Bordetella pertussis DNA [Presence] in Specimen by NAA with probe detection
10
51
1.98
1.12
1.0
1.4
—
—
—
0
0
(3001019) Free T4 and TSH panel - Serum or Plasma
7
137
0.50
1.11
1.7
1.8
—
—
—
0
0
(3020564) Creatinine [Moles/volume] in Serum or Plasma
414
4035
1.49
1.08
45.9
17.5
umol/l
70.3
71.2
0.35
414
4035
(3000492) Spirometry study
21
311
0.66
1.07
1.4
1.6
—
—
—
0
0
(3051611) Lipemic interference index of Serum or Plasma
9
46
1.98
1.04
1.2
2.7
—
—
—
0
0
(3015916) Alpha-1-Fetoprotein [Units/volume] in Serum or Plasma
9
47
1.93
1.02
1.0
1.5
u/ml
3.3
84.9
—
9
47
(3031478) Chlamydophila pneumoniae DNA [Presence] in Specimen by NAA with probe detection
9
47
1.93
1.02
1.0
1.5
—
—
—
0
0
(3008898) HLA-B27 [Presence]
5
110
0.45
1.01
1.0
1.1
—
—
—
0
0
(3043109) Cytology report of Tissue fine needle aspirate Cyto stain
21
140
1.53
0.99
1.1
1.3
—
—
—
0
0
(3029634) Reagin Ab [Titer] in Serum by VDRL
0
30
0.00
0.97
0.0
1.1
—
—
—
0
0
(1001926) Buprenorphine [Presence] in Urine by Screen method
0
30
0.00
0.97
0.0
1.2
—
—
—
0
0
(3053028) Streptococcus sp identified in Specimen by Organism specific culture
0
30
0.00
0.97
0.0
1.4
—
—
—
0
0
(3006257) Acetylcholine receptor Ab [Moles/volume] in Serum
0
31
0.00
0.96
0.0
1.1
—
1.2
—
0
6
(3050238) Crystals [Presence] in Synovial fluid by Light microscopy
6
116
0.51
0.95
1.3
1.4
—
—
—
0
0
(3025941) Bacteria identified in Stool by Culture
31
227
1.39
0.93
1.4
1.3
—
—
—
0
0
(3000034) Microalbumin [Mass/volume] in Urine
6
29
2.08
0.89
4.8
3.9
mg/l
32.8
10.9
—
6
18
(3000620) Complement C3 [Mass/volume] in Serum or Plasma
7
128
0.54
0.89
1.6
1.5
g/l
1.0
1.2
—
7
122
(3027273) Bicarbonate [Moles/volume] in Venous blood
26
186
1.42
0.89
2.2
2.7
mmol/l
24.8
25.4
0.49
26
181
(3014051) Protein [Presence] in Urine by Test strip
17
111
1.55
0.89
4.9
2.4
—
—
—
0
0
(3037121) Protein [Mass/volume] in Urine
20
136
1.49
0.88
9.1
2.5
g/l
0.1
0.2
1.31
13
39
(3004119) Hemoglobin [Mass/volume] in Venous blood
32
240
1.36
0.85
3.7
2.5
g/l
115.9
125.8
1.60
32
234
(3003327) Ova and parasites identified in Stool by Light microscopy
8
139
0.57
0.84
1.6
1.6
—
—
—
0
0
(40768443) Skin Pathology biopsy report
27
197
1.39
0.84
1.0
1.2
—
—
—
0
0
(3042631) Mycobacterium sp identified in Specimen
10
57
1.77
0.84
1.2
2.7
—
—
—
0
0
(40759883) Oligoclonal Bands IgG [Presence] in Cerebral spinal fluid by Isoelectric focusing
0
24
0.00
0.79
0.0
1.0
—
—
—
0
0
(3028707) Methadone [Presence] in Urine by Screen method
0
24
0.00
0.79
0.0
1.3
—
—
—
0
0
(1617658) Protocol used for examination of sentinel lymph nodes
11
66
1.68
0.79
1.1
1.1
—
—
—
0
0
(46235128) Lupus anticoagulant aPTT and dRVVT screening panel W Reflex
0
25
0.00
0.79
0.0
1.1
—
—
—
0
0
(3009991) Angiotensin converting enzyme [Enzymatic activity/volume] in Cerebral spinal fluid
0
25
0.00
0.79
0.0
1.0
—
1.2
—
0
14
(3020565) Legionella pneumophila DNA [Presence] in Specimen by NAA with probe detection
8
48
1.68
0.79
1.0
1.5
—
—
—
0
0
(3017766) Complement C4 [Mass/volume] in Serum or Plasma
7
123
0.56
0.79
1.3
1.6
g/l
0.2
0.2
—
7
117
(3040363) Hepatitis A virus IgG Ab [Presence] in Serum by Immunoassay
0
27
0.00
0.77
0.0
1.0
—
—
—
0
0
(40765161) Human bocavirus DNA [Presence] in Specimen by NAA with probe detection
11
67
1.66
0.75
1.2
1.6
—
—
—
0
0
(3016921) Smith extractable nuclear Ab [Units/volume] in Serum
8
132
0.60
0.74
1.3
1.2
—
2.3
—
0
17
(3024950) Chlamydia trachomatis DNA [Presence] in Urine by NAA with probe detection
8
136
0.58
0.74
1.1
1.5
—
—
—
0
0
(3030692) Respiratory virus DNA+RNA [Identifier] in Specimen by NAA with probe detection
9
57
1.59
0.71
1.2
1.7
—
—
—
0
0
(3027450) Sjogrens syndrome-B extractable nuclear Ab [Units/volume] in Serum
9
143
0.62
0.71
1.2
1.2
—
15.9
—
0
10
(37019628) Gastrointestinal bacterial pathogens panel - Stool by NAA with probe detection
14
93
1.52
0.70
1.4
1.2
—
—
—
0
0
(3022145) Colonoscopy Study observation
40
493
0.79
0.69
1.1
1.2
—
—
—
0
0
(3008757) Leukocyte morphology finding [Identifier] in Blood
7
42
1.68
0.68
1.7
2.9
—
—
—
0
0
(3026910) Gamma glutamyl transferase [Enzymatic activity/volume] in Serum or Plasma
249
2347
1.14
0.68
5.7
2.9
u/l
69.4
46.2
1.73
230
2119
(46235355) HIV 1 and 2 tests - Meaningful Use set
42
340
1.26
0.68
1.1
1.4
—
—
—
0
0
(3025130) Human papilloma virus identified in Specimen
7
44
1.60
0.65
1.6
1.9
—
—
—
0
0
(3017817) Protein [Mass] in Urine collected for unspecified duration
5
29
1.73
0.64
3.8
2.0
—
—
—
0
0
(3041096) Erythrocytes [Presence] in Urine by Automated
113
1014
1.15
0.63
10.0
4.0
—
—
—
0
0
(3022313) Gas panel - Capillary blood
11
163
0.67
0.61
4.0
3.4
—
—
—
0
0
(3045783) Sodium and Potassium panel [Moles/volume] - Serum or Plasma
64
551
1.19
0.59
10.5
7.1
—
—
—
0
0
(3042111) Morphology [Interpretation] in Bone marrow Narrative
10
64
1.58
0.59
1.3
1.4
—
—
—
0
0
(4094501)
7
112
0.62
0.59
1.0
1.1
—
—
—
0
0
(42868691) Thyroxine (T4) free [Moles/volume] in Serum or Plasma by Dialysis
0
23
0.00
0.58
0.0
1.4
—
15.7
—
0
16
(3017704) Immunofixation for Urine
0
23
0.00
0.58
0.0
1.8
—
—
—
0
0
(3015235) Bicarbonate [Moles/volume] in Capillary blood
5
90
0.55
0.56
2.0
3.3
mmol/l
26.2
26.0
—
5
78
(3045414) Leukocytes [Presence] in Urine
25
195
1.30
0.55
4.2
2.1
—
—
—
0
0
(3021440) Promyelocytes/100 leukocytes in Blood
40
332
1.23
0.54
3.8
4.0
%
0.3
0.1
0.55
23
82
(3013139) Helicobacter pylori Ag [Presence] in Stool
23
293
0.77
0.54
1.1
1.3
—
—
—
0
0
(3025159) Blasts/100 leukocytes in Blood
38
315
1.23
0.53
3.9
4.0
%
0.0
1.3
0.49
20
68
(3004490) Bicarbonate [Moles/volume] standard in Capillary blood
9
132
0.68
0.52
4.7
3.6
mmol/l
24.5
25.1
—
9
125
(46235759) Influenza virus B RNA [Presence] in Nasopharynx by NAA with probe detection
10
145
0.68
0.51
1.9
1.7
—
—
—
0
0
(3019800) Troponin T.cardiac [Mass/volume] in Serum or Plasma
167
1566
1.11
0.46
3.0
3.7
ng/l
28.3
51.4
0.50
126
1140
(3017044) Thyrotropin receptor Ab [Units/volume] in Serum
15
112
1.35
0.45
2.1
1.6
iu/l
4.4
4.9
—
7
33
(3015635) Cytomegalovirus IgM Ab [Units/volume] in Serum or Plasma
7
50
1.41
0.45
1.1
1.2
—
—
—
0
0
(40764999) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)
375
3671
1.15
0.45
37.4
14.0
ml/min/173m2
76.2
75.1
0.48
337
2999
(3004716) Salmonella sp identified in Stool by Organism specific culture
24
193
1.26
0.44
1.2
1.3
—
—
—
0
0
(3017918) Cytomegalovirus IgG Ab [Titer] in Serum or Plasma
7
51
1.38
0.44
1.1
1.2
—
—
—
0
0
(40759812) SCL-70 extractable nuclear Ab [Presence] in Serum by Immunoblot
5
32
1.57
0.42
1.2
1.1
—
—
—
0
0
(40759849) Smith extractable nuclear Ab [Presence] in Serum by Immunoblot
5
32
1.57
0.42
1.2
1.1
—
—
—
0
0
(3009595) Pneumocystis jiroveci DNA [Presence] in Specimen by NAA with probe detection
5
32
1.57
0.42
1.4
1.5
—
—
—
0
0
(40759836) Histone Ab [Presence] in Serum by Immunoblot
5
32
1.57
0.42
1.2
1.1
—
—
—
0
0
(40759843) Sjogrens syndrome-A extractable nuclear Ab [Presence] in Serum by Immunoblot
5
33
1.52
0.41
1.2
1.1
—
—
—
0
0
(40759842) Ribonucleoprotein extractable nuclear Ab [Presence] in Serum by Immunoblot
5
33
1.52
0.41
1.2
1.1
—
—
—
0
0
(40759844) Sjogrens syndrome-B extractable nuclear Ab [Presence] in Serum by Immunoblot
5
33
1.52
0.41
1.2
1.1
—
—
—
0
0
(40771527) Human papilloma virus E6+E7 mRNA [Presence] in Cervix by NAA with probe detection
0
16
0.00
0.41
0.0
1.6
—
—
—
0
0
(3017446) Testosterone [Moles/volume] in Serum or Plasma
0
16
0.00
0.41
0.0
1.2
—
1.8
—
0
9
(3026493) Urate [Moles/volume] in Serum or Plasma
106
976
1.11
0.41
2.6
2.4
umol/l
7245.1
6898.3
0.02
100
805
(42868414) European tick borne encephalitis virus IgM Ab [Presence] in Serum by Immunoassay
0
17
0.00
0.40
0.0
1.4
—
—
—
0
0
(3027529) Toxoplasma gondii IgM Ab [Units/volume] in Serum
0
17
0.00
0.40
0.0
1.1
—
—
—
0
0
(3036432) Mycobacterium tuberculosis genotype [Identifier] in Isolate
0
17
0.00
0.40
0.0
5.9
—
—
—
0
0
(40768441) Liver Pathology biopsy report
5
34
1.48
0.40
1.0
1.2
—
—
—
0
0
(3033386) Bacteria [Presence] in Cerebral spinal fluid by Light microscopy
0
18
0.00
0.40
0.0
1.3
—
—
—
0
0
(3047189) Immunofixation for 24 hour Urine
0
18
0.00
0.40
0.0
1.9
—
—
—
0
0
(3025245) SCL-70 extractable nuclear Ab [Units/volume] in Serum by Immunoassay
7
105
0.66
0.39
1.1
1.2
—
8.9
—
0
11
(44813793)
5
35
1.43
0.39
1.0
1.0
—
—
—
0
0
(3021584) Pregnancy associated plasma protein A [Units/volume] in Serum or Plasma
0
19
0.00
0.39
0.0
1.5
—
—
—
0
0
(3014959) Toxoplasma gondii IgG Ab [Units/volume] in Serum
0
19
0.00
0.39
0.0
2.2
—
—
—
0
0
(3010566) Parathyrin.intact [Moles/volume] in Serum or Plasma
11
80
1.38
0.38
1.1
2.2
—
—
—
0
0
(3045424) Erythrocytes [Presence] in Urine
9
66
1.37
0.38
2.2
1.6
—
—
—
0
0
(40760888) Immunoglobulin light chains.free panel - Serum
8
111
0.72
0.37
3.4
4.4
—
—
—
0
0
(3000570) Elastase.pancreatic [Mass/mass] in Stool
18
143
1.27
0.37
1.4
1.3
ug/g
264.7
291.4
0.33
12
84
(46237023) Hepatitis B virus core and surface Ab and surface Ag panel - Serum
9
69
1.31
0.37
1.1
1.1
—
—
—
0
0
(3023520) Reticulocytes [#/volume] in Blood
38
329
1.17
0.36
2.7
2.8
e9/l
65.4
73.8
0.35
19
250
(4306422)
6
41
1.47
0.36
1.0
1.2
—
—
—
0
0
(3013527) Hepatitis B virus core IgM Ab [Presence] in Serum
6
41
1.47
0.36
1.2
1.1
—
—
—
0
0
(3038177) Helicobacter pylori Ab [Presence] in Serum
6
42
1.43
0.35
1.5
1.3
—
—
—
0
0
(4034850)
15
117
1.29
0.35
11.9
8.6
—
—
—
0
0
(3003284) Neutrophil cytoplasmic Ab.perinuclear [Titer] in Serum by Immunofluorescence
10
134
0.74
0.35
1.2
1.6
—
106.7
—
0
6
(3044254) Respiratory syncytial virus RNA [Presence] in Specimen by NAA with probe detection
10
134
0.74
0.35
1.6
1.7
—
—
—
0
0
(3045142) Bone marrow Pathology biopsy report
6
43
1.40
0.35
1.0
1.2
—
—
—
0
0
(3011371) Neisseria gonorrhoeae DNA [Presence] in Specimen by NAA with probe detection
6
44
1.37
0.34
1.2
1.2
—
—
—
0
0
(3010813) Leukocytes [#/volume] in Blood
419
4149
1.24
0.34
55.2
22.1
e9/l
6.5
6.5
0.08
411
4023
(3007461) Platelets [#/volume] in Blood
419
4149
1.24
0.34
55.1
22.1
e9/l
274.4
258.0
3.71
411
4038
(3026361) Erythrocytes [#/volume] in Blood
419
4149
1.24
0.34
55.1
22.1
e12/l
4.0
4.4
43.43
411
4023
(21494670) JAK2 gene exon 14 targeted mutation analysis in Blood or Tissue by Molecular genetics method
6
45
1.34
0.34
1.0
1.0
—
—
—
0
0
(3028626) Oxygen [Partial pressure] in Capillary blood
6
87
0.69
0.33
1.7
3.1
kpa
7.7
7.9
—
6
80
(36033641) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Rapid immunoassay
6
46
1.31
0.33
1.8
1.5
—
—
—
0
0
(3042596) Human coronavirus RNA [Presence] in Specimen by NAA with probe detection
6
47
1.28
0.32
1.2
1.7
—
—
—
0
0
(3016251) Hemoglobin.gastrointestinal [Presence] in Stool
28
239
1.18
0.32
2.1
2.5
—
—
—
0
0
(3000330) Specific gravity of Urine by Test strip
26
223
1.18
0.29
10.3
3.8
—
—
—
0
0
(3019230) Fractional oxyhemoglobin in Venous blood
8
63
1.27
0.28
7.7
1.7
%
62.6
55.1
—
8
63
(40768797) Stomach Pathology biopsy report
59
644
0.90
0.27
1.2
1.2
—
—
—
0
0
(3024135) Streptococcus.beta-hemolytic [Presence] in Throat by Organism specific culture
50
550
0.90
0.27
1.5
1.3
—
—
—
0
0
(4010399)
29
330
0.87
0.26
1.0
1.4
—
—
—
0
0
(36032419) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Immunoassay
5
75
0.66
0.26
1.0
1.7
—
—
—
0
0
(3021788) Differential panel - Synovial fluid
6
84
0.71
0.24
1.7
1.8
—
—
—
0
0
(3043723) Beta 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
15
179
0.83
0.23
1.7
2.3
—
—
—
0
0
(3029338) Protein.monoclonal band 3 [Mass/volume] in Serum or Plasma by Electrophoresis
11
136
0.80
0.23
2.0
2.3
g/l
0.0
0.0
0.00
11
126
(3019050) Tissue transglutaminase IgA Ab [Units/volume] in Serum
86
913
0.93
0.23
1.1
1.2
u/ml
0.5
1.6
1.87
21
227
(3023601) Vancomycin resistant enterococcus [Presence] in Specimen by Organism specific culture
5
39
1.29
0.23
1.6
2.1
—
—
—
0
0
(3021960) Folate [Moles/volume] in Serum or Plasma
99
1045
0.93
0.22
1.8
1.5
nmol/l
18.8
22.6
3.12
93
858
(3020044) Glucose [Moles/volume] in Cerebral spinal fluid
7
93
0.75
0.22
1.0
1.1
mmol/l
3.6
3.8
—
7
86
(3029379) Protein.monoclonal band 4 [Mass/volume] in Serum or Plasma by Electrophoresis
11
135
0.81
0.22
2.0
2.3
g/l
0.0
0.0
0.00
11
125
(43534045) MCM6 gene c.-13910C>T and -13915T>G [Identifier] in Blood or Tissue by Molecular genetics method Nominal
17
199
0.85
0.22
1.0
1.1
—
—
—
0
0
(3035637) Corticotropin [Mass/volume] in Plasma
5
41
1.22
0.22
1.0
1.6
—
—
—
0
0
(3010503) CD19 cells [#/volume] in Blood
0
11
0.00
0.21
0.0
1.4
—
0.1
—
0
11
(40768446) Kidney Pathology biopsy report
0
11
0.00
0.21
0.0
1.1
—
—
—
0
0
(3005033) Fetal Nuchal fold Thickness US
0
11
0.00
0.21
0.0
1.7
—
—
—
0
0
(42528593) TIF1-gamma Ab [Presence] in Serum by Line blot
0
11
0.00
0.21
0.0
1.1
—
—
—
0
0
(42529582) MDA5 Ab [Presence] in Serum by Line blot
0
11
0.00
0.21
0.0
1.1
—
—
—
0
0
(3013637) Mi-2 Ab [Presence] in Serum
0
11
0.00
0.21
0.0
1.1
—
—
—
0
0
(42529598) SUMO-activating enzyme subunit 1 Ab [Presence] in Serum by Line blot
0
11
0.00
0.21
0.0
1.1
—
—
—
0
0
(3047352) Trisomy 18 risk [Likelihood] in Fetus
0
11
0.00
0.21
0.0
1.7
—
—
—
0
0
(42529188) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma by Immunoassay
0
10
0.00
0.21
0.0
1.1
—
—
—
0
0
(42869593) Oxyhemoglobin/Hemoglobin.total [Pure mass fraction] in Capillary blood
0
10
0.00
0.21
0.0
4.4
—
—
—
0
0
(3000081) cloZAPine [Moles/volume] in Serum or Plasma
0
10
0.00
0.21
0.0
16.9
—
2186.5
—
0
10
(3000285) Sodium [Moles/volume] in Blood
0
10
0.00
0.21
0.0
1.0
—
—
—
0
0
(3008832) Norclozapine [Moles/volume] in Serum or Plasma
0
10
0.00
0.21
0.0
15.6
—
1028.5
—
0
10
(40763531) Fetal Nuchal fold [Multiple of the median] Thickness adjusted for maternal weight
0
12
0.00
0.21
0.0
1.8
—
—
—
0
0
(3043238) Trisomy 21 risk [Likelihood] in Fetus
0
12
0.00
0.21
0.0
1.7
—
—
—
0
0
(46235831) Pregnancy associated plasma protein A [Multiple of the median] adjusted in Serum or Plasma
0
12
0.00
0.21
0.0
1.8
—
—
—
0
0
(3008714) Choriogonadotropin [Multiple of the median] adjusted in Serum or Plasma
0
12
0.00
0.21
0.0
1.8
—
—
—
0
0
(3004915) Chlamydophila pneumoniae IgA Ab [Units/volume] in Serum
0
12
0.00
0.21
0.0
1.0
—
—
—
0
0
(3049207) Fetal Trisomy 21 risk [Likelihood] Based on maternal age
0
12
0.00
0.21
0.0
1.8
—
—
—
0
0
(3015816) F5 gene p.Arg506Gln [Presence] in Blood or Tissue by Molecular genetics method
5
43
1.16
0.21
1.0
1.1
—
—
—
0
0
(3032057) Clostridioides difficile [Presence] in Stool
0
13
0.00
0.21
0.0
2.0
—
—
—
0
0
(3023430) Cat dander IgE Ab [Units/volume] in Serum
0
13
0.00
0.21
0.0
1.0
—
1.3
—
0
5
(3030429) Borrelia sp DNA [Identifier] in Specimen by NAA with probe detection
0
13
0.00
0.21
0.0
1.0
—
—
—
0
0
(3042585) Pyridoxine [Moles/volume] in Serum or Plasma
0
13
0.00
0.21
0.0
1.0
—
97.8
—
0
7
(42868415) European tick borne encephalitis virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay
0
14
0.00
0.20
0.0
1.1
—
—
—
0
0
(44806420)
0
14
0.00
0.20
0.0
2.8
—
—
—
0
0
(3046896) Herpes virus 6 DNA [Presence] in Cerebral spinal fluid by NAA with probe detection
0
14
0.00
0.20
0.0
1.1
—
—
—
0
0
(3019145) Choriogonadotropin.beta subunit free [Mass/volume] in Serum or Plasma
0
14
0.00
0.20
0.0
1.6
—
—
—
0
0
(706163) SARS-CoV-2 (COVID-19) RNA [Presence] in Respiratory system specimen by NAA with probe detection
188
1937
0.95
0.20
2.4
2.4
—
—
—
0
0
(3022806) Fractional oxyhemoglobin in Capillary blood
6
52
1.16
0.19
1.5
2.4
%
90.2
89.6
—
6
52
(21493466) Plesiomonas shigelloides DNA [Presence] in Stool by NAA with non-probe detection
6
53
1.13
0.18
1.5
1.3
—
—
—
0
0
(3002179) Metamyelocytes/100 leukocytes in Blood
35
320
1.10
0.17
3.9
3.9
%
0.7
0.5
0.20
16
65
(3021901) Oxygen saturation in Capillary blood
5
69
0.72
0.17
1.8
2.8
—
—
—
0
0
(3021952) Alkaline phosphatase isoenzymes [Enzymatic activity/volume] in Serum or Plasma by Heat stability
6
79
0.76
0.15
1.2
1.2
—
—
—
0
0
(3017895) Helicobacter pylori Ab [Units/volume] in Serum
13
150
0.86
0.15
1.7
1.5
—
—
—
0
0
(3024928) Oxygen saturation in Venous blood
7
88
0.79
0.14
8.9
2.2
—
—
—
0
0
(3007164) IgA [Mass/volume] in Serum or Plasma
72
755
0.94
0.14
1.5
1.6
g/l
1.9
2.4
1.37
34
402
(3029511) Human papilloma virus DNA [Presence] in Specimen by NAA with probe detection
18
161
1.12
0.13
1.1
1.2
—
—
—
0
0
(3028286) Albumin [Mass/volume] in Serum or Plasma by Electrophoresis
13
148
0.87
0.12
1.8
2.3
g/l
37.3
37.8
0.12
13
133
(3027544) Mycobacterium sp identified in Sputum by Organism specific culture
5
45
1.11
0.10
2.8
3.7
—
—
—
0
0
(3023410) Appearance of Cerebral spinal fluid
5
46
1.09
0.09
1.2
1.2
—
—
—
0
0
(42868716) Shigella species+EIEC invasion plasmid antigen H ipaH gene [Presence] in Stool by NAA with probe detection
6
54
1.11
0.09
1.5
1.3
—
—
—
0
0
(3012568) Campylobacter sp identified in Specimen by Organism specific culture
6
54
1.11
0.09
1.5
1.3
—
—
—
0
0
(3005988) Vibrio sp identified in Specimen by Organism specific culture
6
54
1.11
0.09
1.5
1.3
—
—
—
0
0
(3025468) Yersinia sp identified in Specimen by Organism specific culture
6
54
1.11
0.09
1.5
1.3
—
—
—
0
0
(3048929) Epstein Barr virus Ab [Presence] in Serum
6
58
1.03
0.08
1.0
1.2
—
—
—
0
0
(3034770) Mitochondria Ab [Titer] in Serum
9
103
0.87
0.06
1.0
1.2
—
658.6
—
0
7
(3019473) Protein [Mass/volume] in Cerebral spinal fluid
9
104
0.86
0.06
1.0
1.2
mg/l
540.7
523.6
—
9
97
(3024403) Complement+Immunoglobulin [Units/volume] in Red Blood Cells
10
109
0.92
0.04
1.6
1.7
—
—
—
0
0
(3029187) Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Serum or Plasma
131
1296
1.02
0.03
2.3
2.9
ng/l
1229.7
1090.6
0.24
120
1090
(3048689) Calprotectin [Mass/mass] in Stool
50
489
1.03
0.03
1.4
1.9
ug/g
154.6
133.6
0.14
42
369
(3050380) Cytology report of Cervical or vaginal smear or scraping Cyto stain
13
123
1.06
0.01
1.2
1.4
—
—
—
0
0
(3035797) Protein.monoclonal band 2 [Mass/volume] in Serum or Plasma by Electrophoresis
13
137
0.95
0.01
1.8
2.4
g/l
0.0
0.0
0.50
13
127
(3005895) Myoglobin [Mass/volume] in Serum or Plasma
14
134
1.05
0.00
1.8
1.9
ug/l
72.4
186.4
3.22
14
120
(3022621) pH of Urine by Test strip
29
284
1.02
0.00
3.8
3.3
—
—
—
0
0
(3000494) Fungus identified in Specimen by Culture
48
486
0.99
0.00
1.5
1.3
—
—
—
0
0
(40768793) Breast Pathology biopsy report
17
175
0.97
0.00
1.1
1.3
—
—
—
0
0
(1761482) Bacteria [#/volume] in Urine by Culture
11
113
0.97
0.00
7.7
5.0
—
—
—
0
0
(36660697) Celiac disease serology panel - Serum
32
321
1.00
0.00
1.1
1.1
—
—
—
0
0
(3009035) Cobalamin (Vitamin B12) [Moles/volume] in Serum or Plasma
91
909
1.00
0.00
1.6
1.7
pmol/l
97436479.7
17440684.9
0.38
78
711
(3018851) Theophylline [Moles/volume] in Serum or Plasma
0
6
0.00
0.00
0.0
1.5
—
60.7
—
0
6
(3018559) Microscopic observation [Identifier] in Buccal smear by Cyto stain
5
49
1.02
0.00
1.0
1.1
—
—
—
0
0
(3004269) Kappa light chains [Mass/time] in 24 hour Urine
0
6
0.00
0.00
0.0
2.2
—
—
—
0
0
(3024522) Salmonella sp identified in Specimen by Organism specific culture
5
54
0.93
0.00
1.6
1.3
—
—
—
0
0
(3014300) Beta 2 glycoprotein 1 IgM Ab [Units/volume] in Serum
0
6
0.00
0.00
0.0
1.3
—
—
—
0
0
(42868418) European tick borne encephalitis virus IgG Ab [Presence] in Cerebral spinal fluid by Immunoassay
0
6
0.00
0.00
0.0
1.2
—
—
—
0
0
(43055246) Days in therapeutic INR range/Days INR result determined [Ratio]
0
6
0.00
0.00
0.0
16.2
—
78.2
—
0
6
(44816893) Food Allergen Mix 50 (Kiwi+Pineapple+Banana+Mango) IgE Ab [Units/volume] in Serum by Multidisk
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(3002067) Lambda light chains [Mass/time] in 24 hour Urine
0
6
0.00
0.00
0.0
2.2
—
—
—
0
0
(3051101) Glucose [Moles/volume] in Cord blood
0
6
0.00
0.00
0.0
6.0
—
—
—
0
0
(3016330) Potassium [Moles/time] in 24 hour Urine
0
6
0.00
0.00
0.0
1.3
—
—
—
0
0
(44817194) Complement alternate pathway AH50 actual/normal in Serum by Immunoassay
0
6
0.00
0.00
0.0
1.2
—
107.5
—
0
6
(3034037) Hematocrit [Volume Fraction] of Mixed venous blood
0
6
0.00
0.00
0.0
7.2
—
—
—
0
0
(21491866) Provasopressin.C-terminal [Moles/volume] in Serum or Plasma by Immunoassay
0
6
0.00
0.00
0.0
1.2
—
7.6
—
0
6
(3007798) IgG/Albumin [Mass Ratio] in Cerebral spinal fluid
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(21492888) Glucose tolerance 2 hours gestational panel - Serum or Plasma
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(3016650) Hepatitis A virus Ab [Presence] in Serum
5
55
0.91
0.00
1.2
1.0
—
—
—
0
0
(3021513) Carbon dioxide [Partial pressure] in Mixed venous blood
0
6
0.00
0.00
0.0
7.3
—
—
—
0
0
(3038071) Oxygen [Partial pressure] in Mixed venous blood
0
6
0.00
0.00
0.0
7.2
—
—
—
0
0
(3013247) Albumin in CSF/Albumin in Serum or Plasma
0
6
0.00
0.00
0.0
1.0
—
5.6
—
0
6
(3018993) Complement total hemolytic CH100 [Units/volume] in Serum or Plasma
0
6
0.00
0.00
0.0
1.2
—
—
—
0
0
(40760109) Toxoplasma gondii IgG Ab avidity [Ratio] in Serum by Immunoassay
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3035544) Cardiolipin IgG Ab [Units/volume] in Serum or Plasma
0
8
0.00
0.00
0.0
1.3
—
—
—
0
0
(3006093) Chlamydia trachomatis DNA [Presence] in Specimen by NAA with probe detection
6
60
1.00
0.00
1.3
1.3
—
—
—
0
0
(3015616) Isopropanol [Moles/volume] in Serum or Plasma
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3016845) Adenovirus Ag [Presence] in Specimen by Immunofluorescence
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3005011) Chlamydia sp Ab [Titer] in Serum
0
7
0.00
0.00
0.0
1.6
—
—
—
0
0
(42869858) Acute and chronic leukemia fusion transcript panel - Blood or Tissue by Molecular genetics method
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3027300) Silver Birch IgE Ab [Units/volume] in Serum
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3037556) Urate [Mass/volume] in Serum or Plasma
0
7
0.00
0.00
0.0
1.1
—
—
—
0
0
(3032700) Glomerular basement membrane Ab [Units/volume] in Serum
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3026389) Candida sp identified in Specimen by Organism specific culture
6
65
0.92
0.00
1.5
1.4
—
—
—
0
0
(3050129) First trimester maternal screen panel - Serum or Plasma
0
9
0.00
0.00
0.0
1.4
—
—
—
0
0
(3008402) Methanol [Moles/volume] in Serum or Plasma
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3052592) Norovirus Ag [Presence] in Stool
0
5
0.00
0.00
0.0
1.6
—
—
—
0
0
(3020650) Glucose [Presence] in Urine
0
8
0.00
0.00
0.0
2.0
—
—
—
0
0
(3002148) Methylenedioxymethamphetamine [Presence] in Urine by Screen method
0
8
0.00
0.00
0.0
1.4
—
—
—
0
0
(3027231) Wheat IgE Ab [Units/volume] in Serum
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(42868417) European tick borne encephalitis virus IgG Ab [Presence] in Serum by Immunoassay
0
9
0.00
0.00
0.0
1.3
—
—
—
0
0
(1002183) Plasma cells monotypic population [Identifier] in Bone marrow by Flow cytometry (FC)
0
7
0.00
0.00
0.0
1.4
—
—
—
0
0
(3000213) Normetanephrine [Moles/time] in 24 hour Urine
0
9
0.00
0.00
0.0
1.2
—
1.7
—
0
9
(3002670) Multiple inhalant allergen IgE Ab [Units/volume] in Serum
0
8
0.00
0.00
0.0
1.1
—
—
—
0
0
(3022907) Direct antiglobulin test.polyspecific reagent [Presence] on Red Blood Cells
0
8
0.00
0.00
0.0
1.4
—
—
—
0
0
(3006695) Toxoplasma gondii DNA [Presence] in Specimen by NAA with probe detection
0
5
0.00
0.00
0.0
2.4
—
—
—
0
0
(42868499) Enterovirus IgG Ab [Presence] in Cerebral spinal fluid by Immunoassay
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3008116) Ketones [Moles/volume] in Urine by Test strip
0
9
0.00
0.00
0.0
1.6
—
—
—
0
0
(3020073) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Specimen
0
8
0.00
0.00
0.0
1.5
—
—
—
0
0
(3015076) Soybean IgE Ab [Units/volume] in Serum
0
7
0.00
0.00
0.0
1.0
—
—
—
0
0
(3022689) Creatine [Moles/volume] in Urine
0
8
0.00
0.00
0.0
1.6
—
—
—
0
0
(3042975) Streptococcus sp identified in Isolate by Organism specific culture
0
8
0.00
0.00
0.0
1.0
—
—
—
0
0
(3042733) HLA Ab [Presence] in Serum
0
5
0.00
0.00
0.0
3.4
—
—
—
0
0
(3013603) Prostate specific Ag [Mass/volume] in Serum or Plasma
0
8
0.00
0.00
0.0
1.1
—
—
—
0
0
(3029715) Chromosome analysis.interphase [Interpretation] in Bone marrow by FISH Narrative
0
7
0.00
0.00
0.0
1.0
—
—
—
0
0
(3008536) Aspergillus sp Ab [Presence] in Serum
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3048879) Bone marrow aspiration report
0
9
0.00
0.00
0.0
1.9
—
—
—
0
0
(3037534) Parathyrin related protein [Mass/volume] in Serum or Plasma
0
7
0.00
0.00
0.0
1.4
—
88.3
—
0
7
(3013327) Hepatitis A virus IgM Ab [Presence] in Serum
5
50
1.00
0.00
1.2
1.0
—
—
—
0
0
(3046299) Protein.monoclonal [Mass/volume] in Serum or Plasma by Electrophoresis
0
8
0.00
0.00
0.0
7.6
—
—
—
0
0
(3001729) Color of Synovial fluid
0
5
0.00
0.00
0.0
1.2
—
—
—
0
0
(3011436) Histone Ab [Units/volume] in Serum
0
8
0.00
0.00
0.0
1.1
—
—
—
0
0
(3028371) Actinomyces sp identified in Specimen by Organism specific culture
0
5
0.00
0.00
0.0
1.4
—
—
—
0
0
(3013784) Calcium.ionized [Moles/volume] in Serum or Plasma by Ion-selective membrane electrode (ISE)
0
8
0.00
0.00
0.0
1.1
—
—
—
0
0
(3016228) CD19 cells/100 cells in Blood
0
8
0.00
0.00
0.0
1.5
—
3.3
—
0
8
(4015189)
0
9
0.00
0.00
0.0
3.3
—
—
—
0
0
(3011335) Digoxin [Mass/volume] in Serum or Plasma
0
5
0.00
0.00
0.0
2.4
—
—
—
0
0
(4198724)
0
9
0.00
0.00
0.0
1.0
—
—
—
0
0
(3035457) Cefaclor IgE Ab [Units/volume] in Serum
0
9
0.00
0.00
0.0
1.2
—
—
—
0
0
(21494814) CD8 cells/100 lymphocytes in Specimen
0
8
0.00
0.00
0.0
1.5
—
—
—
0
0
(3044290) Cell count panel - Cerebral spinal fluid
7
76
0.92
0.00
1.0
1.1
—
—
—
0
0
(3044941) Cell count panel - Synovial fluid
7
78
0.90
0.00
1.6
1.6
—
—
—
0
0

Mortality – FinRegistry

↥

This endpoint is excluded from FinRegistry analyses (omitted endpoint).

Relationships between endpoints

↥

Index endpoint: C3_FEMALE_GENITAL_NAS – Malignant neoplasm of other and unspecified female genital organs

GWS hits: -

This endpoint is excluded from FinRegistry analyses (omitted endpoint).